95 related articles for article (PubMed ID: 3119205)
1. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Rankin EM; Harvey C; Knight RK; Rubens RD
Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
[No Abstract] [Full Text] [Related]
2. Prednimustine in advanced breast cancer: a review.
Mouridsen HT
Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
[TBL] [Abstract][Full Text] [Related]
3. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
[No Abstract] [Full Text] [Related]
4. [A phase II study of prednimustine in advanced ovarian cancer].
Grundsell H; Johnsson JE; Tropé C
Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
[No Abstract] [Full Text] [Related]
5. Prednimustine in advanced malignant melanoma: a phase II study.
Pedersen L; Løber J; Dalmark M; Mouridsen HT
Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
[No Abstract] [Full Text] [Related]
6. Phase II trial of prednimustine in glioblastoma multiforme.
Andersen J; Christensen L; Kongsholm H
Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
[TBL] [Abstract][Full Text] [Related]
7. Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Marini G; Simoncini E; Marpicati P; Montini E; Ferrari V; Arcangeli G; Zaniboni A
Chemioterapia; 1988 Apr; 7(2):130-2. PubMed ID: 2840216
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
[TBL] [Abstract][Full Text] [Related]
9. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
10. Prednimustine in elderly patients with multiple myeloma: a phase II study.
Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
[No Abstract] [Full Text] [Related]
11. Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Gaynon PS; Baum ES; Krivit W; Hammond D
Cancer Treat Rep; 1982 Jul; 66(7):1583-4. PubMed ID: 6284362
[No Abstract] [Full Text] [Related]
12. Prednimustine in advanced soft tissue sarcomas.
Karakousis CP; Didolkar MS; Ambrus JL; Holyoke ED
Cancer Treat Rep; 1982 Jan; 66(1):201-2. PubMed ID: 7053259
[No Abstract] [Full Text] [Related]
13. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Boesen E; Mouridsen HT
Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
[TBL] [Abstract][Full Text] [Related]
14. [Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ueno K; Imajou K; Miyaoka K; Ozeki H
Gan To Kagaku Ryoho; 1987 Jan; 14(1):173-8. PubMed ID: 3541792
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparative study of prednimustine and doxorubicin in patients with metastatic breast cancer.
Allegra JC
Semin Oncol; 1986 Mar; 13(1 Suppl 1):42-4. PubMed ID: 3513319
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
Jensen HS; Hansen HH; Dombernowsky P
Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
Kosmidis PA; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
Chemioterapia; 1987 Dec; 6(6):393-5. PubMed ID: 3435921
[TBL] [Abstract][Full Text] [Related]
18. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
[TBL] [Abstract][Full Text] [Related]
19. Prednimustine in acute nonlymphocytic leukemia.
Ayulo MA; Preisler HD
Am J Clin Oncol; 1983 Apr; 6(2):207-9. PubMed ID: 6829495
[No Abstract] [Full Text] [Related]
20. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]